PRESS RELEASE published on 09/17/2026 at 20:00, 28 days 12 hours ago Informations privilégiées / Autres communiqués ABL Diagnostics devient ABL Texcell Diagnostics, confirmant le maintien de la cotation sur Euronext Paris. La Société élargit ses activités de diagnostic moléculaire et virologie Euronext Paris Diagnostic Moléculaire ABL Diagnostics Virologie ABL Texcell Diagnostics
PRESS RELEASE published on 09/17/2026 at 20:00, 28 days 12 hours ago Inside Information / Other news releases ABL Diagnostics changes name to ABL Texcell Diagnostics. Shareholders decide to remain listed on Euronext Paris for long-term growth. New identity reflects growth in molecular diagnostics, virology, and life sciences Euronext Paris Life Sciences Molecular Diagnostics Virology ABL Texcell Diagnostics
BRIEF published on 09/14/2026 at 20:05, 1 month 1 day ago ABL Diagnostics publie son dernier rapport de recherche Rentabilité Croissance Des Revenus Conseils Financiers Rapport De Recherche Diagnostics ABL
BRIEF published on 09/14/2026 at 20:05, 1 month 1 day ago ABL Diagnostics Releases Latest Research Report Revenue Growth Profitability Financial Guidance Research Report ABL Diagnostics
PRESS RELEASE published on 09/14/2026 at 20:00, 1 month 1 day ago Informations privilégiées / Autres communiqués ABL Diagnostics publie le rapport d'analyse d'All Invest Securities, confirmant sa recommandation d'achat et son objectif de cours pour l'année en cours Recommandation D'achat Objectif De Cours ABL Diagnostics All Invest Securities Rapport D'analyse
PRESS RELEASE published on 09/14/2026 at 20:00, 1 month 1 day ago Inside Information / Other news releases ABL Diagnostics announces availability of the latest equity research report by All Invest Securities highlighting strong revenue growth and maintained target price of €8.7 per share Revenue Growth Target Price Equity Research Report ABL Diagnostics All Invest Securities
BRIEF published on 09/11/2026 at 12:06, 1 month 4 days ago ABL Diagnostics Files Takeover Bid for IntegraGen Molecular Diagnostics Takeover Bid IntegraGen ABL Diagnostics Genomic Analysis
BRIEF published on 09/11/2026 at 12:06, 1 month 4 days ago ABL Diagnostics dépose une offre publique d'achat sur IntegraGen. Offre Publique D'achat Diagnostic Moléculaire IntegraGen Diagnostics ABL Analyse Génomique
PRESS RELEASE published on 09/11/2026 at 12:01, 1 month 4 days ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) ABL Diagnostics annonce le dépôt d'une offre de reprise d'IntegraGen, société spécialisée en analyse génomique, dans le cadre de sa stratégie de croissance externe Croissance Externe Offre De Reprise IntegraGen ABL Diagnostics Analyse Génomique
PRESS RELEASE published on 09/11/2026 at 12:01, 1 month 4 days ago Inside Information / Operations of the issuer (acquisitions, sales...) ABL Diagnostics announces takeover bid for IntegraGen, a genomic analysis company. Acquisition subject to Commercial Court decision. ABLD focuses on molecular diagnostics solutions and growth strategy Growth Strategy Molecular Diagnostics Takeover Bid IntegraGen ABL Diagnostics
Published on 10/16/2026 at 08:00, 46 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 10/16/2026 at 05:55, 2 hours 51 minutes ago Collective Metals Announces Private Placement of Hard Dollar and Flow-Through Units
Published on 10/16/2026 at 02:10, 6 hours 36 minutes ago Nova Scotia Silver Explorer TruSilver Metals Corp. Anticipates TSXV Trading Under "TAG" on October 27
Published on 10/16/2026 at 01:45, 7 hours 1 minute ago Faraday Copper Closes the Acquisition of the San Manuel Project in Arizona and Mobilizes Drill Rigs
Published on 10/16/2026 at 01:30, 7 hours 16 minutes ago LNG Energy Group Announces Closing of Second Tranche of Private Placement
Published on 10/16/2026 at 07:30, 1 hour 15 minutes ago Steyr Motors and drone specialist Avilus are cooperating on the power supply for the Grille unmanned aircraft system
Published on 10/16/2026 at 07:00, 1 hour 45 minutes ago PolyPeptide Group: Definitive interim result of the public tender offer of Samsung Biologics Co., Ltd.
Published on 10/15/2026 at 22:30, 10 hours 15 minutes ago Porsche Mission S: the essence of the sports car reinterpreted
Published on 10/16/2026 at 07:30, 1 hour 16 minutes ago Chiffre d'affaires du troisième trimestre 2026
Published on 10/15/2026 at 18:50, 13 hours 56 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 18:50, 13 hours 56 minutes ago Trafic du mois de septembre et des 9 premiers mois de l'année 2026 - Révision des hypothèses de trafic pour l'année 2026
Published on 10/15/2026 at 18:16, 14 hours 29 minutes ago Déclaration des droits de vote au 30 septembre 2026
